Latest Sales And Development News

Lendlease and Bizzi & Partners have extended the deadline for conditions attached to the proposed sale of Lendlease’s MSG North development rights in Milan. Closing remains uncertain, with Lendlease warning it may need to fund approximately $160 million of project obligations if the transaction fails.

Prophecy International’s revenue fell 15% and its statutory loss widened to $7.9 million in FY26, leaving the software group with $1 million in cash and negative net assets. A major restructure, new debtor finance facility and AI product launch offer a recovery plan, but the auditor has warned of material uncertainty around the company’s ability to continue as a going concern.

Artrya has launched its AI-powered Salix® platform commercially in the US, securing three foundation health systems and raising $80 million to fuel growth. With FDA clearance for its Coronary Plaque module and a pivotal clinical study underway, the company is poised for scaling revenues amid a strong balance sheet.

Atomo Diagnostics lifted revenue 41% to AUD 5.33 million for FY26, cutting its loss by 29% to AUD 3.51 million, driven by HIV self-testing growth and a key US partnership. Leadership changes signal a strategic pivot as the company eyes global expansion.

Australis Oil & Gas Ltd posted a $2.6 million net loss for 1H 2026 amid sharply reduced production volumes but is progressing its Tuscaloosa Marine Shale development with a key partner and a planned Q4 well spud.

Blue Star Helium has completed the commissioning phase of its Pinon Canyon helium plant, secured a three-month helium offtake agreement with a major US buyer, and begun selling helium as it prepares for production ramp-up in the second half of 2026.

HITIQ Limited has fortified its financial position through a $1.4 million placement and secured milestone-based Victorian Government funding, accelerating its manufacturing expansion and commercial growth in concussion management technology.

Elsight Limited (ASX:ELS) has shattered its revenue records in H1 2026, delivering a nearly fourfold increase over the prior year alongside expanding US defence contracts and new product launches.

Beetaloo Energy's Carpentaria-5H shale gas well delivered a steady 6.9 TJ/day average over a 30-day flow test, reinforcing the quality of the Velkerri Shale reservoir and supporting recoverable gas estimates ahead of the Carpentaria Gas Plant commissioning.

Lindian Resources has terminated its monazite concentrate sales agreement with Gerald Metals, issuing 20 million shares as part of the deal and reclaiming full control over its Kangankunde Rare Earths Project sales strategy.

UOA Development Bhd’s Q1 2026 results reveal a decline in revenue and profit compared to last year, despite a solid RM130.7 million in new property sales and a substantial unbilled sales pipeline.

Oceania Healthcare Limited has delivered a standout FY26 with 16% higher sales, 20% EBITDA growth, and a 19% reduction in net debt, setting the stage for positive cash flow in FY27 despite no dividend declared this year.